PIN1 in breast development and cancer: a clinical perspective.
about
A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action.Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology.Inhibition of CDK-mediated Smad3 phosphorylation reduces the Pin1-Smad3 interaction and aggressiveness of triple negative breast cancer cells.Peptidyl-prolyl cis/trans isomerase Pin1 regulates withaferin A-mediated cell cycle arrest in human breast cancer cells.Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways.Pin1 Is Involved in HDAC6-mediated Cancer Cell Motility
P2860
PIN1 in breast development and cancer: a clinical perspective.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
PIN1 in breast development and cancer: a clinical perspective.
@en
PIN1 in breast development and cancer: a clinical perspective.
@nl
type
label
PIN1 in breast development and cancer: a clinical perspective.
@en
PIN1 in breast development and cancer: a clinical perspective.
@nl
prefLabel
PIN1 in breast development and cancer: a clinical perspective.
@en
PIN1 in breast development and cancer: a clinical perspective.
@nl
P2093
P2860
P50
P356
P1476
PIN1 in breast development and cancer: a clinical perspective
@en
P2093
Alessandra Rustighi
Elena Campaner
Giannino Del Sal
P2860
P2888
P304
P356
10.1038/CDD.2016.122
P577
2016-11-11T00:00:00Z